Use of intravenous iron and risk of anaphylaxis: A multinational observational post‐authorisation safety study in Europe-Reference-Cited by-同舟云学术

Use of intravenous iron and risk of anaphylaxis: A multinational observational post‐authorisation safety study in Europe

Published:2021-07-12 Issue:10 Volume:30 Page:1447-1457
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Fortuny Joan¹^ORCID,Gersdorff Gero²^ORCID,Lassalle Régis³^ORCID,Linder Marie⁴^ORCID,Overbeek Jetty⁵^ORCID,Reinold Jonas⁶^ORCID,Toft Gunnar⁷^ORCID,Timmer Antje⁸^ORCID,Dress Jochen⁹,Blin Patrick³^ORCID,Droz‐Perroteau Cécile³^ORCID,Ehrenstein Vera⁷^ORCID,Franzoni Carla¹,Herings Ron⁵¹⁰^ORCID,Kollhorst Bianca⁶^ORCID,Moore Nicholas³^ORCID,Odsbu Ingvild⁴^ORCID,Perez‐Gutthann Susana¹^ORCID,Schink Tania⁶^ORCID,Rascher Katherine²,Rasouliyan Lawrence¹^ORCID,Rothman Kenneth J.¹¹^ORCID,Saigi‐Morgui Nuria¹^ORCID,Schaller Mathias²,Smits Elisabeth⁵,Forstner Michael¹²^ORCID,Bénichou Jacques¹³^ORCID,Bircher Andreas J.¹⁴¹⁵^ORCID,Garbe Edeltraut⁶^ORCID,Rampton David S.¹⁶,Gutierrez Lia¹^ORCID,

Affiliation:

1. Pharmacoepidemiology and Risk Management RTI Health Solutions Barcelona Spain

2. Department of Internal Medicine–QiN‐group University of Cologne, Faculty of Medicine and University Hospital Cologne Cologne Germany

3. Bordeaux PharmacoEpi INSERM CIC1401, University of Bordeaux Bordeaux France

4. Centre for Pharmacoepidemiology Karolinska Institutet Stockholm Sweden

5. Department Research PHARMO Institute for Drug Outcomes Research Utrecht The Netherlands

6. Clinical Epidemiology Group Leibniz Institute for Prevention Research and Epidemiology–BIPS Bremen Germany

7. Department of Clinical Epidemiology Aarhus University Aarhus Denmark

8. Epidemiology and Biometry Group Carl von Ossietzky University Oldenburg Oldenburg Germany

9. Research Data Center (DaTraV) Federal Institute for Drugs and Medical Devices–BfArM Bonn Germany

10. Amsterdam UMC Vrije Universiteit Amsterdam, Epidemiology and Biostatistics Amsterdam The Netherlands

11. Pharmacoepidemiology and Risk Management RTI Health Solutions Waltham Massachusetts USA

12. Mesama Consulting Solothurn Switzerland

13. Department of Biostatistics Rouen University Hospital and Inserm U 1018, University of Rouen Rouen France

14. Allergy Unit Dermatology Clinic University Hospital Basel Basel Switzerland

15. Faculty of Biomedicine Università della Svizzera italiana Lugano Switzerland

16. Department of Gastroenterology Royal London Hospital London UK

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.5319

Reference18 articles.

1. Clinical Use of Intravenous Iron: Administration, Efficacy, and Safety

2. Differences in the reporting rates of serious allergic adverse events from intravenous iron by country and population;Bailie GR;Clin Adv Hematol Oncol,2012

3. WalshK AndradeS CocorosN et al.Sentinel assessment report: parenteral iron and anaphylactoid reactions.US Food and Drug Administration; 22 July2016.https://www.sentinelinitiative.org/sites/default/files/surveillance‐tools/routine‐querying/Sentinel_Parenteral‐Iron‐and‐Anaphylactoid‐Reactions_Report.pdf. Accessed 6 October 2020.

4. Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products

5. On the relative safety of parenteral iron formulations

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypersensitivity reactions associated with iron isomaltoside and ferric carboxymaltose;European Journal of Internal Medicine;2023-04

2. Hypersensitivity to Intravenous Iron Preparations;Children;2022-09-27

3. Risks for Anaphylaxis With Intravenous Iron Formulations;Annals of Internal Medicine;2022-05

4. Validity of hospital ICD‐10‐GM codes to identify anaphylaxis;Pharmacoepidemiology and Drug Safety;2021-09